|
|
||||||||
1Department of Microbiology, Medical University of Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria 2Department of Gastroenterology, University Paediatric Hospital, Sofia, Bulgaria
Correspondence Lyudmila Boyanova lboyanova{at}hotmail.com
Received February 25, 2004
Accepted May 21, 2004
Risk factors for primary Helicobacter pylori resistance in 186 children with gastroduodenal diseases (44 from villages/small towns and 130 from large towns/cities) in 20002003 were tested. Susceptibility was tested by a limited agar dilution method. Overall resistance rates to metronidazole, clarithromycin, tetracycline and both metronidazole and clarithromycin were 14.5, 11.9, 3.3 and 4.3 %, respectively. No amoxycillin resistance was observed. Tetracycline resistance was found in six children aged 718 years. Clarithromycin resistance was more common in children from small towns/villages (22.7 %) than in those from large towns/cities (8.5 %, P < 0.05). There were no significant differences (P > 0.05) in resistance rates between children from northern Bulgaria and those from southern regions. Resistance rates in duodenal ulcer patients and other children were, respectively, 10.5 and 15 % (P > 0.20) for metronidazole and 10.5 and 12 % (P > 0.20) for clarithromycin. No combined resistance to metronidazole and clarithromycin was found in 22 children aged 17 years and in 34 children living in northern Bulgaria. There were no significant associations of resistance with sex and age group (17- versus 818-year-old children) for all antibacterial agents tested. In conclusion, primary H. pylori resistance was absent (for metronidazole + clarithromycin) or low (4.5 % for clarithromycin) in children aged 17 years. Place of residence was associated with clarithromycin resistance rates.
This article has been cited by other articles:
![]() |
A. J. Lawson, N. C. Elviss, and R. J. Owen Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales J. Antimicrob. Chemother., August 1, 2005; 56(2): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |